Yoneda, S.; Uta, D.; Yasufuku, K.; Yamane, T.; Yoshioka, S.; Takasu, K.; Izumi, T.; Fujita, S.; Nakamori, D.; Kawasaki, S.;
et al. A Systemically Administered Humanized Anti-Nav1.7 Antibody with Long-Lasting Analgesic Activity and Preserved Physiological Nociception. Pharmaceutics 2026, 18, 757.
https://doi.org/10.3390/pharmaceutics18060757
AMA Style
Yoneda S, Uta D, Yasufuku K, Yamane T, Yoshioka S, Takasu K, Izumi T, Fujita S, Nakamori D, Kawasaki S,
et al. A Systemically Administered Humanized Anti-Nav1.7 Antibody with Long-Lasting Analgesic Activity and Preserved Physiological Nociception. Pharmaceutics. 2026; 18(6):757.
https://doi.org/10.3390/pharmaceutics18060757
Chicago/Turabian Style
Yoneda, Sosuke, Daisuke Uta, Kana Yasufuku, Takuya Yamane, Saho Yoshioka, Keiko Takasu, Takaya Izumi, Sayaka Fujita, Daiki Nakamori, Shiori Kawasaki,
and et al. 2026. "A Systemically Administered Humanized Anti-Nav1.7 Antibody with Long-Lasting Analgesic Activity and Preserved Physiological Nociception" Pharmaceutics 18, no. 6: 757.
https://doi.org/10.3390/pharmaceutics18060757
APA Style
Yoneda, S., Uta, D., Yasufuku, K., Yamane, T., Yoshioka, S., Takasu, K., Izumi, T., Fujita, S., Nakamori, D., Kawasaki, S., Takahashi, T., Yoshikawa, M., Ogawa, K., & Kasai, E.
(2026). A Systemically Administered Humanized Anti-Nav1.7 Antibody with Long-Lasting Analgesic Activity and Preserved Physiological Nociception. Pharmaceutics, 18(6), 757.
https://doi.org/10.3390/pharmaceutics18060757
